Rani Therapeutics Holdings Inc Cl A (RANI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -40,950 | -31,876 | -23,962 | -12,738 | -56,584 |
| Depreciation Amortization | 829 | 730 | 449 | 159 | 13 |
| Accounts receivable | -2,042 | N/A | 428 | -600 | N/A |
| Accounts payable and accrued liabilities | -1,050 | 1,108 | 439 | 161 | 711 |
| Other Working Capital | 6,958 | 984 | 1,244 | 28 | -544 |
| Other Operating Activity | 17,541 | 10,046 | 7,457 | 4,841 | 20,908 |
| Operating Cash Flow | $-18,714 | $-19,008 | $-13,945 | $-8,149 | $-35,496 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -6,942 | 24,030 | 24,030 | 18,280 | 20,077 |
| PPE Investments | -88 | -88 | -88 | -51 | -268 |
| Investing Cash Flow | $-7,030 | $23,942 | $23,942 | $18,229 | $19,809 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -20,722 | -11,250 | -7,500 | -3,750 | -5,000 |
| Common Stock Issued | 61,081 | 6,736 | 3,988 | 42 | 18,632 |
| Other Financing Activity | -59 | -38 | -31 | -23 | -47 |
| Financing Cash Flow | $40,300 | $-4,552 | $-3,543 | $-3,731 | $13,585 |
| Beginning Cash Position | 4,262 | 4,262 | 4,262 | 4,262 | 6,364 |
| End Cash Position | 18,818 | 4,644 | 10,716 | 10,611 | 4,262 |
| Net Cash Flow | $14,556 | $382 | $6,454 | $6,349 | $-2,102 |
| Free Cash Flow | |||||
| Operating Cash Flow | -18,714 | -19,008 | -13,945 | -8,149 | -35,496 |
| Capital Expenditure | -88 | -88 | -88 | -51 | -268 |
| Free Cash Flow | -18,802 | -19,096 | -14,033 | -8,200 | -35,764 |